Are You in Control of Your Data

Corgenix to Present Ebola Abstracts at 2015 AACC Clinical Lab Expo

Corgenix Medical Corporation, the U.S. based operation of ORGENTEC Diagnostika, is presenting several scientific abstracts at the 2015 American Association for Clinical Chemistry (AACC) Clinical Lab Expo in Atlanta.

On July 28 in the AACC Clinical Studies/Outcomes session, Corgenix will present poster A-003 “Clinical validation of the ReEBOV Antigen Rapid Test Kit for the point of care detection of Ebola Virus Disease.”

On July 29, Corgenix will present two posters during the Infectious Disease session: poster B-074 “Analytical validation of the ReEBOV Antigen Rapid Test Kit for the point of care detection of Ebola Virus Disease;” and poster B-072 “Preliminary validation of saliva samples as clinical matrix on the ReEBOV Antigen Rapid Test Kit for the point of care detection of Ebola Virus Disease.”

The Corgenix ReEBOV Ebola rapid test was the first RDT and the first immunoassay authorized for emergency use by the FDA for the presumptive detection of Ebola virus. In February 2015, it was also listed as eligible for procurement by the World Health Organization in the fight against the West Africa Ebola outbreak.


     
Tags: Ebola virus

Date Published: July 27, 2015

Source article link: Corgenix » company contact details
Join us on Google+

© 2001 - 2017 Rapid Test Methods Ltd • Please join us on Twitter, Facebook and LinkedIn • RSS Feed